zoledronic acid has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beelen, KJ; Bornebroek, M; Geijteman, ECT; Loef, M; Schweitzer, DH | 1 |
| Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ | 1 |
2 other study(ies) available for zoledronic acid and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
[Relapse of chronic inflammatory demyelinating polyneuropathy following treatment with zoledronic acid].
Topics: Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Neoplasm Recurrence, Local; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Zoledronic Acid | 2017 |
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid | 2019 |